November 17th 2023
Reva K Basho, MD, discusses the use of antibody-drug conjugates across the spectrum of breast cancer subtypes at the 2023 Bridging the Gaps in Breast Cancer meeting.
August 13th 2021
Reva K. Basho, MD, discusses the emergence of bispecific antibodies in HER2-positive breast cancer.
July 28th 2021
Reva K. Basho, MD, discusses the evolution of therapeutic sequencing in HER2-positive breast cancer.
July 22nd 2021
Reva K. Basho, MD, discusses the integration of fam-trastuzumab deruxtecan-nxki in HER2-positive breast cancer.